---
title: "GeneDx - CW27 | 8-K: FY2025 Q1 Revenue: USD 87.12 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238263084.md"
datetime: "2025-04-30T11:04:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238263084.md)
  - [en](https://longbridge.com/en/news/238263084.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238263084.md)
generator: "portal-rs"
---

# GeneDx - CW27 | 8-K: FY2025 Q1 Revenue: USD 87.12 M

Revenue: As of FY2025 Q1, the actual value is USD 87.12 M.

EPS: As of FY2025 Q1, the actual value is USD -0.23.

### Segment Revenue

-   **Total Revenue**: $87.1 million, a 42% increase year-over-year.
-   **Exome and Genome Test Revenue**: $71.4 million, a 62% increase year-over-year.

### Operational Metrics

-   **Adjusted Net Income**: $7.7 million compared to an adjusted net loss of $8.0 million in the first quarter of 2024.
-   **GAAP Net Loss**: $6.5 million.
-   **Adjusted Gross Margin**: 69%, compared to 61% in the first quarter of 2024.
-   **Total GAAP Gross Margin**: 67%.
-   **Adjusted Total Operating Expenses**: $52.3 million, or 60% of revenues, compared to 74% in the first quarter of 2024.

### Cash Flow

-   **Cash Position**: $160.2 million as of March 31, 2025.
-   **Cash Generated from Operations**: $4.1 million.
-   **Proceeds from Stock Issuance**: $13.9 million.

### Unique Metrics

-   **Exome and Genome Test Volume**: 20,562, a 24% increase year-over-year.
-   **Planned Acquisition**: GeneDx announced plans to acquire Fabric Genomics, with the transaction expected to close in Q2 2025.

### Outlook / Guidance

-   GeneDx raised its full year 2025 revenue guidance to between $360 and $375 million, inclusive of $3 to $5 million from the planned acquisition of Fabric Genomics.
-   The company expects growth in exome/genome volume and revenue of at least 30% and adjusted gross margins between 66%-68%.
-   GeneDx anticipates profitability with adjusted net income each quarter and for the full year 2025.

### Related Stocks

- [WGSWW.US](https://longbridge.com/en/quote/WGSWW.US.md)

## Related News & Research

- [TECHNICALS-US oil may retest resistance at $92.89](https://longbridge.com/en/news/298251483.md)
- [Oil rises as risks of prolonged Mideast conflict heighten supply worries](https://longbridge.com/en/news/298241307.md)
- [Where Will Paramount Skydance (NASDAQ:PSKY) Move To?](https://longbridge.com/en/news/298231998.md)
- [Is TTM Technologies (TTMI) Fully Valued Following Its AI Driven Earnings Beat?](https://longbridge.com/en/news/298240590.md)
- [DHT Holdings (DHT) Faces Dividend Durability Questions As Valuation Looks Fully Valued](https://longbridge.com/en/news/298240860.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**